Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis

Hashem H Ghoraba,1 Wataru Matsumiya,1,2 Hassan Khojasteh,1 Amir Akhavanrezayat,1 Irmak Karaca,1 Christopher Or,1 Negin Yavari,1 Sherin Lajevardi,1 Jaclyn Hwang,1 Cigdem Yasar,1 Diana Do,1 Quan Dong Nguyen1 1Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA,...

Full description

Bibliographic Details
Main Authors: Ghoraba HH, Matsumiya W, Khojasteh H, Akhavanrezayat A, Karaca I, Or C, Yavari N, Lajevardi S, Hwang JJ, Yasar C, Do D, Nguyen QD
Format: Article
Language:English
Published: Dove Medical Press 2022-05-01
Series:Clinical Ophthalmology
Subjects:
pediatric uveitis
intravenous methylprednisolone
adverse events
Online Access:https://www.dovepress.com/safety-of-intravenous-methylprednisolone-in-refractory-and-severe-pedi-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/safety-of-intravenous-methylprednisolone-in-refractory-and-severe-pedi-peer-reviewed-fulltext-article-OPTH

Similar Items